These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23869836)

  • 41. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
    Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
    Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
    Chen MJ; Yang WS; Chen CL; Wu MY; Yang YS; Ho HN
    Hum Reprod; 2008 Apr; 23(4):952-7. PubMed ID: 18256110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Measurement of serum AMH levels in gynecology: indications and limits].
    Streuli I; Cantero-Perez P; Miserez-Zaugg C
    Rev Med Suisse; 2013 Oct; 9(403):1954-6, 1958. PubMed ID: 24245018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anti-Müllerian hormone - a marker of ovarian function].
    Koskela S; Tapanainen J
    Duodecim; 2016; 132(3):226-32. PubMed ID: 26951026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
    Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.
    Chen Y; Ye B; Yang X; Zheng J; Lin J; Zhao J
    J Int Med Res; 2017 Jun; 45(3):1138-1147. PubMed ID: 28449632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical applications of anti-Müllerian hormone in evaluating ovarian reserve functions].
    Yu M; Deng CY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):114-9. PubMed ID: 19317075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-Müllerian hormone dynamics during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Dąbkowska-Huć A; Lemm M; Sikora J; Witek A; Skałba P
    Endokrynol Pol; 2013; 64(3):203-7. PubMed ID: 23873424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of anti-Müllerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome.
    Safier LZ; Grossman LC; Chan CW; Sauer MV; Lobo RA; Douglas NC
    Int J Gynaecol Obstet; 2016 Oct; 135(1):73-6. PubMed ID: 27350232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.
    Somunkiran A; Yavuz T; Yucel O; Ozdemir I
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):196-201. PubMed ID: 17335955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is there a place for AMH testing in Canada?
    Green JA; Graves G
    J Obstet Gynaecol Can; 2011 Jun; 33(6):628-632. PubMed ID: 21846454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
    Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
    J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bariatric Surgery Reduces Serum Anti-mullerian Hormone Levels in Obese Women With and Without Polycystic Ovarian Syndrome.
    Chiofalo F; Ciuoli C; Formichi C; Selmi F; Forleo R; Neri O; Vuolo G; Paffetti P; Pacini F
    Obes Surg; 2017 Jul; 27(7):1750-1754. PubMed ID: 28378209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
    La Marca A; Volpe A
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):603-10. PubMed ID: 16712660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Age-related trends in anti-Mullerian hormone serum level in women with unilateral and bilateral ovarian endometriomas prior to surgery.
    Nieweglowska D; Hajdyla-Banas I; Pitynski K; Banas T; Grabowska O; Juszczyk G; Ludwin A; Jach R
    Reprod Biol Endocrinol; 2015 Nov; 13():128. PubMed ID: 26596960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.